Search

everythinglearnresearchcommunity

for

Search:↓

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

Targeting dermal adipocytes may help combat skin aging.

Overexpressing the mineralocorticoid receptor in mouse skin causes skin thinning, early skin barrier development, eye issues, and hair loss.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Both mouse and rat models are effective for testing alopecia areata treatments.

Activating Nrf2 protects human hair follicles from oxidative stress and helps prevent hair growth inhibition.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

Some medications can cause acne, and stopping these drugs is the main treatment.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Valproic acid may help hair grow and could be a safe treatment for hair loss.

Intralesional triamcinolone acetonide is the most effective treatment for localized alopecia areata.

Some treatments can help with hair regrowth in alopecia areata, but results vary and long-term use is often needed without changing the disease's outcome.

Androgens significantly affect female hair loss, and hormonal treatments may help.

Bcl-2 overexpression protects against UVB damage but worsens hair loss from chemotherapy.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

Many patients find hair loss from chemotherapy very distressing, and while treatments like minoxidil and scalp cooling may help, there is no sure way to prevent it.

People with atopic dermatitis are more likely to develop other skin conditions due to shared genetics and immune pathways.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Ginsenoside F2 from ginseng may increase hair growth better than standard treatments by affecting cell growth signals.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

Using a gene therapy with the Sonic Hedgehog gene helps mice regrow hair faster after losing it from chemotherapy.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Shikimic acid promotes hair growth.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Chemotherapy can cause hair changes similar to alopecia areata, which might lead to misdiagnosis.